Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nadroparin, ATC B01AB06

AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseEisenberg, GermanyNot disclosed712 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 50%

Complexity: low

712 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Open house procedure for non-exclusive discount agreements on Nadroparin (ATC B01AB06) with AOK Rheinland-Pfalz/Saarland. Pharmaceutical companies can join at any time up to May 2028. The procedure is not a classic procurement under EU directive; it is a voluntary transparency publication. No estimated value is provided.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Must be a pharmaceutical company (pharmazeutisches Unternehmen)
Medicinal products must be authorized and marketable in Germany (Lauer-Taxe listing or AMIce proof)
Submission of signed contract documents with qualified electronic signature or in paper form

Buyer

Name

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse

Location

Eisenberg, DEU

[email protected]

Website

www.aok.de/rheinland-pfalz-saarland/

Buyer profile

Open profile

Identifier

DE271900642

Lots (1)

#LOT-0001Open house Arzneimittelrabattverträge zum Wirkstoff Nadroparin, ATC B01AB06

Non-exclusive discount agreements for Nadroparin. Duration up to 24 months from August 2026. Can be terminated by replacement with exclusive contracts. Open to all pharmaceutical companies meeting eligibility.

33600000DEU